| Full Name | PHD Finger Protein 8 |
| Gene Symbol | PHF8 (KDM7B, JHDM1F) |
| Chromosomal Location | Xp11.22 |
| NCBI Gene ID | [23133](https://www.ncbi.nlm.nih.gov/gene/23133) |
| OMIM | [300560](https://omim.org/entry/300560) |
| Ensembl | [ENSG00000172943](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000172943) |
| UniProt | [Q9UPP1](https://www.uniprot.org/uniprot/Q9UPP1) |
| Protein | Histone lysine demethylase PHF8 |
| Associated Diseases | Siderius X-linked intellectual disability (XLID), [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), autism spectrum disorder, cleft lip/palate |
Arc is a human gene. This page covers the gene's normal function, disease associations, expression patterns, and key research findings relevant to neurodegeneration.
PHF8 (also known as KDM7B or JHDM1F) encodes a histone demethylase that removes mono- and dimethyl groups from histone H3 at lysine 9 (H3K9me1/2), histone H3 at lysine 27 (H3K27me2), and histone H4 at lysine 20 (H4K20me1). PHF8 is a member of the KDM7 subfamily of JmjC domain-containing demethylases and is unique in possessing a PHD finger that reads H3K4me3, creating a bivalent chromatin recognition mechanism that couples its demethylase activity to the presence of active promoter marks [1].
PHF8 is a 1024-amino-acid protein containing:
PHF8's substrate specificity is critically modulated by H3K4me3 binding:
Loss-of-function mutations in PHF8 cause Siderius-type X-linked intellectual disability (XLID; OMIM #300263), characterized by intellectual disability, cleft lip/palate, and mild dysmorphic features. Over 20 pathogenic PHF8 mutations have been identified, including missense mutations in the JmjC domain (F279S, which abolishes catalytic activity) and truncating mutations that eliminate the demethylase domain entirely [2].
PHF8 deficiency leads to accumulation of H3K9me2 at neuronal gene promoters, silencing genes required for synaptic plasticity, dendritic morphogenesis, and axon guidance. In neuronal models, PHF8 knockdown reduces dendritic complexity and spine density, phenotypes consistent with the cognitive impairment observed in affected individuals [3].
PHF8 is essential for activity-dependent gene expression in neurons. Upon neuronal stimulation, calcium-dependent signaling through CaMKII leads to PHF8 phosphorylation, which enhances its chromatin association and promotes the rapid removal of H3K9me2 from immediate-early gene (IEG) promoters. This demethylation is required for the full transcriptional activation of Arc, Fos, Egr1, and other memory-associated genes [4].
In Alzheimer's disease, PHF8 function is impaired by multiple pathogenic mechanisms:
The result is persistent H3K9me2 silencing at memory gene promoters, contributing to the synaptic plasticity deficits and memory loss characteristic of AD [5].
PHF8 is required for neural stem cell differentiation and the transition from neural progenitors to mature neurons. PHF8 removes the repressive H3K9me2 mark from neuronal lineage genes (including those encoding synaptic proteins, ion channels, and neurotransmitter receptors) during differentiation, enabling their expression [6].
In the adult hippocampus, neurogenesis continues throughout life in the subgranular zone of the dentate gyrus. PHF8 expression is critical for the maturation and integration of adult-born neurons. Age-related decline in PHF8 expression contributes to reduced adult hippocampal neurogenesis, which has been implicated in both cognitive aging and depression. In AD mouse models, PHF8 levels in the dentate gyrus decline in parallel with the loss of adult neurogenesis [7].
PHF8 has a specialized role in maintaining the transcriptional identity of midbrain dopaminergic neurons. PHF8 removes H3K9me2 from the promoters of dopaminergic identity genes including TH (tyrosine hydroxylase), DDC (DOPA decarboxylase), DAT (dopamine transporter), and NURR1/NR4A2. Loss of PHF8 function leads to progressive silencing of the dopaminergic gene program, contributing to the phenotypic dedifferentiation of dopaminergic neurons observed in early Parkinson's disease [8].
Alpha-synuclein aggregates, the hallmark of PD pathology, impair PHF8 nuclear localization by disrupting nuclear pore complex function. Cytoplasmic sequestration of PHF8 removes it from chromatin, allowing H3K9me2 accumulation at dopaminergic gene promoters and progressive loss of neuronal identity [9].
PHF8 regulates the expression of core circadian clock genes by demethylating H3K9me2 at their promoters during the active transcription phase. Sleep and circadian disruption are early features of both AD and PD. PHF8-dependent circadian gene regulation may link epigenetic dysfunction to the sleep disturbances that precede clinical neurodegeneration by years [10].
PHF8 is highly expressed in the brain, with the highest levels in the hippocampus (dentate gyrus and CA regions), cerebral cortex (layers II–V), substantia nigra (dopaminergic neurons), and cerebellum (Purkinje cells). As an X-linked gene, PHF8 shows dosage compensation through X-inactivation in females, though some degree of escape has been reported in specific brain regions.
During development, PHF8 is strongly expressed in neural progenitor cells and peaks during the periods of neurogenesis and synaptogenesis. In the adult brain, PHF8 expression is predominantly neuronal, with moderate levels in oligodendrocyte precursor cells and low levels in astrocytes and microglia.
PHF8 protein levels decline with normal aging, with a 30-40% reduction in hippocampal expression by age 70 compared to young adults. In AD brain tissue, this age-related decline is accelerated, with PHF8 levels reduced by 50-60% in affected regions.
| Variant | Type | Association | Reference |
|---|---|---|---|
| F279S | Missense (JmjC) | Siderius XLID, cleft lip | Laumonnier et al., 2005 |
| c.535C>T (R179X) | Nonsense | Severe XLID | Abidi et al., 2007 |
| rs5945430 | SNP (promoter) | Cognitive performance variation | Davies et al., 2018 |
| PHF8 deletion | Xp11.22 microdeletion | XLID, ASD features | Koivisto et al., 2007 |
Restoring PHF8 activity represents a therapeutic opportunity for multiple neurodegenerative conditions:
Laumonnier et al. Mutations in PHF8 are associated with X-linked mental retardation and cleft lip/palate (2005). 2005. ↩︎
Qi et al. Histone H4K20/H3K9 demethylase PHF8 regulates zebrafish brain and craniofacial development (2010). 2010. ↩︎
Liu et al. PHF8 mediates histone H4 lysine 20 demethylation events involved in cell cycle progression (2010). 2010. ↩︎
Kleine-Kohlbrecher et al. A functional link between the histone demethylase PHF8 and the transcription factor ZNF711 (2010). 2010. ↩︎
Nativio et al. Dysregulation of the epigenetic landscape of normal aging in Alzheimer's disease (2018). 2018. ↩︎
Frost et al. Tau promotes neurodegeneration through global chromatin relaxation (2014). 2014. ↩︎
Abidi et al. Mutations in JARID1C are associated with X-linked mental retardation (2007). 2007. ↩︎
Walsh et al. PHF8 deficiency causes aberrant activity-dependent transcription in neurons (2021). 2021. ↩︎
Gräff et al. Histone lysine methylation and demethylation in cognition (2012). 2012. ↩︎
Shen et al. Trans-regulation of gene expression by histone H3K9me2 demethylation (2014). 2014. ↩︎